242 related articles for article (PubMed ID: 18329613)
1. Selective killing of nonreplicating mycobacteria.
Bryk R; Gold B; Venugopal A; Singh J; Samy R; Pupek K; Cao H; Popescu C; Gurney M; Hotha S; Cherian J; Rhee K; Ly L; Converse PJ; Ehrt S; Vandal O; Jiang X; Schneider J; Lin G; Nathan C
Cell Host Microbe; 2008 Mar; 3(3):137-45. PubMed ID: 18329613
[TBL] [Abstract][Full Text] [Related]
2. A new antituberculosis drug that selectively kills nonmultiplying Mycobacterium tuberculosis.
Mitchison DA
Cell Host Microbe; 2008 Mar; 3(3):122-4. PubMed ID: 18329610
[TBL] [Abstract][Full Text] [Related]
3. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide.
Darwin KH; Ehrt S; Gutierrez-Ramos JC; Weich N; Nathan CF
Science; 2003 Dec; 302(5652):1963-6. PubMed ID: 14671303
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1.
Mori M; Deodato D; Kasula M; Ferraris DM; Sanna A; De Logu A; Rizzi M; Botta M
Bioorg Med Chem Lett; 2018 Feb; 28(4):637-641. PubMed ID: 29395975
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting DosRST as a new approach to tuberculosis therapy.
Zheng H; Abramovitch RB
Future Med Chem; 2020 Mar; 12(5):457-467. PubMed ID: 32053005
[TBL] [Abstract][Full Text] [Related]
7. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
Gold B; Warrier T; Nathan C
Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
[TBL] [Abstract][Full Text] [Related]
8. Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection.
Sukumar N; Tan S; Aldridge BB; Russell DG
PLoS Pathog; 2014 Sep; 10(9):e1004394. PubMed ID: 25233380
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo.
Chawla M; Parikh P; Saxena A; Munshi M; Mehta M; Mai D; Srivastava AK; Narasimhulu KV; Redding KE; Vashi N; Kumar D; Steyn AJ; Singh A
Mol Microbiol; 2012 Sep; 85(6):1148-65. PubMed ID: 22780904
[TBL] [Abstract][Full Text] [Related]
10. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
[TBL] [Abstract][Full Text] [Related]
11. Targeting Phenotypically Tolerant Mycobacterium tuberculosis.
Gold B; Nathan C
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28233509
[TBL] [Abstract][Full Text] [Related]
12. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
13. Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes.
Venugopal A; Bryk R; Shi S; Rhee K; Rath P; Schnappinger D; Ehrt S; Nathan C
Cell Host Microbe; 2011 Jan; 9(1):21-31. PubMed ID: 21238944
[TBL] [Abstract][Full Text] [Related]
14. Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.
Subhedar DD; Shaikh MH; Shingate BB; Nawale L; Sarkar D; Khedkar VM; Kalam Khan FA; Sangshetti JN
Eur J Med Chem; 2017 Jan; 125():385-399. PubMed ID: 27688192
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide rich extract (PRE) from Tinospora cordifolia inhibits the intracellular survival of drug resistant strains of Mycobacterium tuberculosis in macrophages by nitric oxide induction.
Gupta PK; Kulkarni S
Tuberculosis (Edinb); 2018 Dec; 113():81-90. PubMed ID: 30514517
[TBL] [Abstract][Full Text] [Related]
16. Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis.
Shi S; Ehrt S
Infect Immun; 2006 Jan; 74(1):56-63. PubMed ID: 16368957
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model.
Grant SS; Kawate T; Nag PP; Silvis MR; Gordon K; Stanley SA; Kazyanskaya E; Nietupski R; Golas A; Fitzgerald M; Cho S; Franzblau SG; Hung DT
ACS Chem Biol; 2013 Oct; 8(10):2224-34. PubMed ID: 23898841
[TBL] [Abstract][Full Text] [Related]
18. Impact of
Camassa S; Palucci I; Iantomasi R; Cubeddu T; Minerva M; De Maio F; Jouny S; Petruccioli E; Goletti D; Ria F; Sali M; Sanguinetti M; Manganelli R; Rocca S; Brodin P; Delogu G
Front Cell Infect Microbiol; 2017; 7():137. PubMed ID: 28484686
[TBL] [Abstract][Full Text] [Related]
19. Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks.
Tomioka H; Tatano Y; Sano C; Shimizu T
J Infect Chemother; 2011 Jun; 17(3):302-17. PubMed ID: 21243398
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
